BUSINESS

EU States Greenlight Landmark New AI Rules

Brussels spent most of last year racing to greenlight the draft text after chatbot ChatGPT exploded onto the scene
The European Union's 27 member states on Friday approved landmark rules on reining in artificial intelligence, passing a key last hurdle after tough negotiations to the very end.
More news
This handout photo from the  US Drug Enforcement Administration (DEA) shows 40 mg pills of OxyContin

Publicis Settles Opioid Case With US States For $350 Mn

Publicis Health, part of the French advertising giant Publicis, worked with Purdue Pharma between 2010 and 2019 on marketing material to promote OxyContin and other drugs, New York Attorney General Letitia James said in a press release.
Finland's Prime Minister Petteri Orpo said a major two day strike in his country will damage the economy

Thousands Strike In Finland Over Labour Reform

A massive Finnish strike movement kicked off on Thursday, grounding most air traffic and closing workplaces in a protest against proposed government labour reforms that include social benefit cuts.
Traffic has been backing up on major roads due to blockades

Defiant French Farmers Stick To Barricades

France's farmers showed little sign on Thursday of abandoning their protest despite government concessions in response to a movement that has spread nationwide and elsewhere in Europe.
Shell's net profit reached $19.4 billion in 2023

Shell Profit Tumbles On Lower Oil Prices

Shell said Thursday that its net profit more than halved to $19.4 billion in 2023 on lower energy prices, after rocketing to a record peak the previous year following the Ukraine conflict.
People from states of Khartoum and al-Jazira, displaced by the ongoing conflict in Sudan between the army and paramilitaries, wait to receive aid from a charity organisation in Gedaref on December 30, 2023

US Deplores Holdups On Aid Into Sudan

The United States on Wednesday implored Sudan's authorities to let aid into the country, denouncing holdups as the war between rival generals leaves millions in need of help.
Biogen said it was discontinuing Aduhelm to put more resources into Leqembi, a newer Alzheimer's medicine that was fully approved in 2023 under the traditional regulatory pathway

Biogen Pulls Controversial Alzheimer's Drug Aduhelm

A controversial Alzheimer's drug that was trumpeted as the first to ever treat the cognitive decline associated with the devastating brain disorder has been pulled from the market, its maker Biogen announced Wednesday.

Pages

IBT Spotlight

We Help Businesses Find B2B Service Providers They Can Trust.